Navigation Links
Zeus Debuts Enhanced Website
Date:2/10/2009

ORANGEBURG, S.C., Feb. 10 /PRNewswire/ -- Zeus, Inc. is pleased to introduce its enhanced company website. The new site is live and accessible via http://www.zeusinc.com.

With innovative graphics and bold colors, the site is a user-friendly resource for comprehensive information about Zeus products and its analytical, research, and developmental services.

The website conveniently organizes an extensive amount of information into four categories listed on the site's homepage: Extrusion Services, Analytical Services, Research & Development, and Technical Services. Also accessible are an online catalog and technical bulletins. The technical bulletins section includes equations, methods, properties, and other technical information regarding Zeus products. Users will also be able to access an extensive list of Zeus technical newsletters covering a range of informative and novel topics related to the field of polymer science.

About Zeus, Inc.:

Zeus, Inc. is headquartered in Orangeburg, SC USA. Zeus is a world leader in the design and production of high-performance polymer tubing used in demanding applications; operating multiple facilities in North America and internationally. Zeus products and services are preferred by companies in medical, automotive, electrical, fluid handling, and mechanical markets. For more information, visit http://www.zeusinc.com.

    Press Contact:
    Samantha D. Farlow
    (803) 268-9500

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Zeus, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Award-winning QUITPLAN(R) Services Billboard Debuts in Rogers
2. Virgin America Airline Debuts With MedAire Services
3. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
4. Mirixa Debuts RxFYI - a Free Pharmacy-Published Health eNewsletter Building Patient Loyalty and Generating Revenue
5. Health Insurance Finders Debuts A Comprehensive Guide to Family Health Insurance
6. Rutgers biomaterial debuts in clinical trials of new stent
7. Long Term Care Newsletter Debuts, Published by LTC Financial Partners; Advice on Living Better, Not Just Longer, With Financial Protection
8. Omnicell Debuts Industrys First Total Automated Patient-Specific Management Solution
9. A Whole New Sandwich Debuts in the Freezer Aisle: LEAN POCKETS(R) Brand Introduces Latest Whole Grain Varieties
10. Two Little Hands Productions, Creators of Popular Childrens TV Series Signing Time, Debuts Second Season at This Years Toy Fair 2008
11. Merging discovery with therapy: Second generation memory care debuts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... Hackensack, N.J. (PRWEB) , ... April 26, 2017 ... ... fluency, Inc. in Hackensack, N.J. has been honored by Enterprising Women magazine ... program that recognizes the world’s top women business owners. Winners have demonstrated that ...
(Date:4/26/2017)... ... 2017 , ... RawTrition now brings you BioEnergy which is a powder capsule ... , RawTrition is taking nutrients to the next level! The superfoods in ... raw form (unlike the synthetically made options that are on the market). , Founder ...
(Date:4/26/2017)... FL (PRWEB) , ... April 26, 2017 , ... ... and human performance, is proud to announce that it has received 510(k) clearance ... technologies, the MyoCycle Home and the MyoCycle Pro. , Both devices are stationary ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and ... its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne ...
(Date:4/25/2017)... ... 2017 , ... The doctors at Wall Centre Dental are now expanding their ... require sedation to receive dental care. The doctors offer three treatment options to put ... to oral surgery, at their dental office in Vancouver. Wall Centre Dental is currently ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
Breaking Medicine Technology: